[CME "Takotsubo cardiomyopathy].
Peter
P
Weidmann
D017023:Coronary Angiography / Q000187:drug effects; D003329:Coronary Vasospasm / Q000139:chemically induced* / Q000175:diagnosis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D017202:Myocardial Ischemia / Q000139:chemically induced* / Q000175:diagnosis; D023303:Oxazolidinones / Q000009:adverse effects* / Q000627:therapeutic use; D010353:Patient Education as Topic; D012307:Risk Factors; D058825:Serotonin 5-HT1 Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D013315:Stress, Psychological / Q000150:complications*; D054549:Takotsubo Cardiomyopathy / Q000139:chemically induced* / Q000175:diagnosis; D014363:Tryptamines / Q000009:adverse effects* / Q000627:therapeutic use
D023303:Oxazolidinones; D058825:Serotonin 5-HT1 Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan